Shares of Sinopharm Group Co. Ltd. (OTCMKTS:SHTDF – Get Free Report) passed below its 200-day moving average during trading on Monday . The stock has a 200-day moving average of $2.37 and traded as low as $1.99. Sinopharm Group shares last traded at $1.99, with a volume of 2,000 shares.
Sinopharm Group Stock Performance
The company has a 50-day moving average of $2.13 and a 200-day moving average of $2.37.
Sinopharm Group Company Profile
Sinopharm Group Co, Ltd is one of China’s largest state-owned integrated healthcare companies, primarily focused on the research, development, production and distribution of a broad range of pharmaceutical and healthcare products. Established in 1998 through the reorganization of assets under China National Pharmaceutical Group (Sinopharm), the company has grown to encompass multiple business segments, including prescription medicines, over-the-counter drugs, vaccines and medical devices. Sinopharm Group is listed on the Hong Kong Stock Exchange and trades in the United States through its OTCMKTS ticker SHTDF.
The company’s product portfolio spans chemically synthesized drugs, biologics and traditional Chinese medicine formulations, supported by an extensive nationwide manufacturing and quality-control network.
Featured Articles
- Five stocks we like better than Sinopharm Group
- Striking Oil: How the U.S. Play for Venezuela Fuels Supermajors
- J.M. Smucker Stock’s Rally Has More Than Tariffs Behind It
- Wendy’s Rally Fades After Trian Steps Back: Was It Ever Real?
- GitLab’s Earnings Beat Just Gave Software Bulls a New SaaSpocalypse Test
Receive News & Ratings for Sinopharm Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sinopharm Group and related companies with MarketBeat.com's FREE daily email newsletter.
